Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study. J of Skin. 2018;2(S1):S54. doi:10.25251/skin.2.supp.54